MacroGenics
MGNX
#9189
Rank
A$0.15 B
Marketcap
A$2.40
Share price
-1.73%
Change (1 day)
-44.63%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): A-$0.20

According to MacroGenics's latest financial reports the company's current EPS (TTM) is A-$0.07056. In 2024 the company made an earnings per share (EPS) of A-$1.51 a decrease over its 2023 EPS that were of A-$0.21.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.20-86.88%
2024A-$1.51613.33%
2023A-$0.21-92.31%
2022A-$2.75-42.14%
2021A-$4.7636.44%
2020A-$3.49-21.84%
2019A-$4.46-24.58%
2018A-$5.91675.93%
2017A-$0.76-68.05%
2016A-$2.38168.25%
2015A-$0.89-55%
2014A-$1.983400%
2013A-$0.05645-108.68%
2012A$0.6524.49%
2011A$0.52

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.92-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$32.49-46,139.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$20.22-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$9.20-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.31-14,713.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.19-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A-$2.50 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA